Medication for management of pregnancy-induced hypertension
Por um escritor misterioso
Descrição
Hypertension refers to increased arterial blood pressure and can be divided into two categories: primary and secondary. Primary hypertension caused by angiogenic degenerative changes is a degenerative disease. With liberalization of China’s reproduction policy and increases in maternal age, the prevalence of pregnancy-induced hypertension (PIH) in China has increased gradually. PIH is not a type of primary hypertension, but there are differences in the treatment of these two types of hypertension. Here, we review the choice and use of drugs for PIH management using drugs for the management of primary hypertension as a reference. First-line drugs such as labetalol, nifedipine, or methyldopa should be taken via the oral route if blood pressure is ≥ 150/90 mmHg. For chronic hypertension, other drugs should be added after the first drug at the highest concentration has been revealed to be ineffective. If the blood pressure of patients with acute hypertension is ≥ 160/110 mmHg, maternal stroke or eclampsia can result. If PIH patients are about to deliver, they can be given labetalol (i.v.), hydralazine (i.v.) or nifedipine (p.o.). Moreover, all anti-hypertensive treatments should be based on considerations of maternal and fetal safety.
Simplified algorithm for management of hypertension in pregnancy. DBP
HYPERTENSIVE DISEASE IN PREGNANCY
Lesson: Review of Hypertension in Pregnancy for Pharmacists
PPT - Hypertension in Pregnancy PowerPoint Presentation, free download - ID:1895010
Nutrients, Free Full-Text
Hypertension and Pregnancy: Overview, Chronic Hypertension, Differential Diagnosis
Guidelines for diagnosis and treatment of hypertensive disorders of
Cover Story Gestational Hypertension and Preeclampsia: Nontraditional Risk Factors For Cardiovascular Disease - American College of Cardiology
Furosemide for Accelerated Recovery of Blood Pressure Postpartum in Women with a Hypertensive Disorder of Pregnancy
Gestational Hypertension American Pregnancy Association
Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization — United States, 2017–2019
de
por adulto (o preço varia de acordo com o tamanho do grupo)
